Source: Annual Congress 2009 - PG6 Core Curriculum Postgraduate Course: How to reduce the burden of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Decramer (Leuven, Belgium). Rationale for active detection of COPD. Annual Congress 2009 - PG6 Core Curriculum Postgraduate Course: How to reduce the burden of COPD

Member's Comments

No comment yet.

Related content which might interest you: Screening for and early detection of COPD: feasibility and impact Source: Annual Congress 2009 - LANCET/ERS symposium: “Evolving dimensions of COPD” Year: 2009 Early diagnostics of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 515s Year: 2004 Active detection of COPD, methods and results Source: Annual Congress 2009 - PG6 Core Curriculum Postgraduate Course: How to reduce the burden of COPD Year: 2009 Phenotype-based therapy of COPD: Effect on the rate of COPD exacerbations Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Effectiveness of a comprehensive management program of fragile COPD patients Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Validation of a new inhaled therapeutic algorithm for the stable COPD patient: The COPD easy treatment project Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015 Monitoring of new pulmonary TB patients: detection and treatment Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009 Potential usefulness of phenotyping in asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Distribution and outcomes of the new Spanish phenotype-based guideline for COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Onbrace: A real-life evaluation of indacaterol maintenance treatment for COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Approaches to TB prediction in patients with COPD Source: Virtual Congress 2021 – Health effects of tobacco and medical professionals Year: 2021 Role of biomarkers in the assessment and phenotyping asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Recommendations for pharmacological treatment of exacerbations of COPD Source: International Congress 2017 – Treatment and prevention of COPD exacerbation Year: 2017 Therapeutic options for COPD exacerbations Source: International Congress 2014 – PG04 Update on COPD exacerbations Year: 2014 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Implications of under treatment of stable COPD (SAVING study) Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Efficacy of early COPD diagnosis and intervention system Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014